Langer I - Search Results

1

Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2).

Langer I, Gaspard N, Robberecht P. Langer I, et al. Br J Pharmacol. 2006 Aug;148(8):1051-9. doi: 10.1038/sj.bjp.0706816. Epub 2006 Jun 19. Br J Pharmacol. 2006. PMID: 16783404 Free PMC article.

2

Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas.

Langer I, Vertongen P, Perret J, Fontaine J, Atassi G, Robberecht P. Langer I, et al. Med Pediatr Oncol. 2000 Jun;34(6):386-93. doi: 10.1002/(sici)1096-911x(200006)34:6<386::aid-mpo2>3.0.co;2-3. Med Pediatr Oncol. 2000. PMID: 10842244

3

Eriochrome Black T inhibits endothelial cell growth through S-phase blockade.

Langer I, Atassi G, Robberecht P, Résibois A. Langer I, et al. Eur J Pharmacol. 2000 Jul 7;399(2-3):85-90. doi: 10.1016/s0014-2999(00)00370-8. Eur J Pharmacol. 2000. PMID: 10884506

4

Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction.

Solano RM, Langer I, Perret J, Vertongen P, Juarranz MG, Robberecht P, Waelbroeck M. Solano RM, et al. Among authors: langer i. J Biol Chem. 2001 Jan 12;276(2):1084-8. doi: 10.1074/jbc.M007696200. J Biol Chem. 2001. PMID: 11013258 Free article.

5

Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.

Vertongen P, Solano RM, Perret J, Langer I, Robberecht P, Waelbroeck M. Vertongen P, et al. Among authors: langer i. Br J Pharmacol. 2001 Aug;133(8):1249-54. doi: 10.1038/sj.bjp.0704195. Br J Pharmacol. 2001. PMID: 11498510 Free PMC article.

6

Vasoactive intestinal peptide (VIP) stimulates [Ca2+]i and cyclic AMPin CHO cells expressing Galpha16.

Langer I, Perret J, Vertongen P, Waelbroeck M, Robberecht P. Langer I, et al. Cell Calcium. 2001 Oct;30(4):229-34. doi: 10.1054/ceca.2001.0230. Cell Calcium. 2001. PMID: 11587546

7

Characterization of functional VIP/PACAP receptors in the human erythroleukemic HEL cell line.

Lema-Kisoka R, Hayez N, Langer I, Robberecht P, Sariban E, Delporte C. Lema-Kisoka R, et al. Among authors: langer i. Peptides. 2001 Dec;22(12):2155-62. doi: 10.1016/s0196-9781(01)00567-8. Peptides. 2001. PMID: 11786204

8

Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue.

Perret J, Van Craenenbroeck M, Langer I, Vertongen P, Gregoire F, Robberecht P, Waelbroeck M. Perret J, et al. Among authors: langer i. Biochem J. 2002 Mar 1;362(Pt 2):389-94. doi: 10.1042/0264-6021:3620389. Biochem J. 2002. PMID: 11853547 Free PMC article.

9

A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector.

Langer I, Vertongen P, Perret J, Waelbroeck M, Robberecht P. Langer I, et al. Mol Endocrinol. 2002 May;16(5):1089-96. doi: 10.1210/mend.16.5.0822. Mol Endocrinol. 2002. PMID: 11981043

10

VPAC(1) receptors have different agonist efficacy profiles on membrane and intact cells.

Langer I, Vertongen P, Perret J, Cnudde J, Gregoire F, De Neef P, Robberecht P, Waelbroeck M. Langer I, et al. Cell Signal. 2002 Aug;14(8):689-94. doi: 10.1016/s0898-6568(02)00009-8. Cell Signal. 2002. PMID: 12020769

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters